CIRCON CORP
10-Q/A, 1996-06-05
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: EUROPACIFIC GROWTH FUND, 497, 1996-06-05
Next: ARCTCO INC, PRE 14A, 1996-06-05



                                 FORM 10-Q/A

                    SECURITIES AND EXCHANGE COMMISSION

                          WASHINGTON, D.C.  20549

                               AMENDMENT #1
                                  





QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934

FOR QUARTER ENDED    March 31, 1996              COMMISSION FILE NO.  0-12025 


CIRCON CORPORATION                                                          
(Exact Name of Registrant as Specified in Its Charter)


         Delaware                                        95-3079904         
(State or other jurisdiction of                        (I.R.S. Employer
 incorporation or organization)                         Identification No.)



6500 Hollister Avenue, Santa Barbara, California       93117-3019           
(Address of Principal Executive Offices)               (Zip Code)


Registrant's telephone number, including area code:  (805) 685-5100         


          Indicate by check mark whether the registrant (1) has
          filed all reports required to be filed by Section 13
          or 15(d) of the Securities Exchange Act of 1934
          during the preceding twelve months (or for such shorter
          period that the registrant was required to file such
          reports), and (2) has been subject to such filing 
          requirements for the past 90 days.

                         Yes  X         No    


Number of Common Shares Outstanding at March 31, 1996:   12,574,196       




                             CIRCON CORPORATION AND SUBSIDIARIES

                           CONSOLIDATED STATEMENTS OF OPERATIONS

                                 Three Months Ended March, 31 

                            (In thousands, except per share amounts)


                                          (UNAUDITED)           (UNAUDITED)
                                               1995                  1996
                                          ----------             ---------
NET SALES                              $     37,921         $      39,962

    Cost of sales                            17,398                17,764
                                          ----------             ---------
GROSS PROFIT                                 20,523                22,198


OPERATING EXPENSES:
     Research and development                2,612                  2,975
     Selling, general and administrative    15,848                 15,645
                                         ----------             ----------   
     Total operating expenses               18,460                 18,620

INCOME FROM OPERATIONS                       2,063                  3,578

     Interest income                           363                     95
     Interest expense                       (1,440)                (1,128)
     Other income (expense), net                53                    (62)
                                         ----------             ------------
INCOME  BEFORE PROVISION FOR INCOME TAXES    1,039                  2,483

     Provision  for income taxes               418                    824
                                         ----------             -----------
NET INCOME                             $       621            $     1,659
                                         ==========             ===========    

EARNINGS  PER SHARE                    $      0.05            $      0.13
                                         ==========             ===========
Weighted Average Number of Shares of Common
Stock and Equivalents Outstanding           12,778                 13,114
                                         ==========              ==========

                           The accompanying notes are an integral part of
                                     these consolidated statements.




                  CIRCON CORPORATION AND SUBSIDIARIES

                 CONSOLIDATED STATEMENTS OF CASH FLOWS

                     Three Months Ended March, 31

                             (In Thousands) 



CASH FLOWS FROM OPERATING ACTIVITIES                   1995        1996
                                                    --------     -------

  Net income                                            621       1,659

  Adjustments to reconcile net
      income  to cash provided by (used in)
      operating activities:

     Depreciation and amortization                    2,476       2,380
     Deferred income taxes                                8         310


Change in assets and liabilities:
     Accounts receivable                                394      (1,030)
     Inventories                                       (935)     (1,003)
     Prepaid expenses and other assets                 (148)       (785)
     Other assets                                       272         123
     Accounts payable                                   814      (2,302)
     Accrued liabilities                             (1,706)       (172)
     Customer deposits                                   13         112
                                                    ---------   ---------       
Net cash provided by (used in) operating activities   1,809        (708)
                                                    ---------   ---------




                               CIRCON CORPORATION AND SUBSIDIARIES

                               CONSOLIDATED STATEMENTS OF CASH FLOWS

                                   Three Months Ended March, 31
 
                                          (In Thousands)


CASH FLOWS FROM INVESTING ACTIVITIES                        1995       1996
                                                         --------    --------
     Disposals of marketable securities, net                 318       5,911
     Purchases of property, plant and equipment           (3,549)     (2,365)
     Cumulative translation adjustment                       448         577
                                                         --------    --------
     Net cash provided by (used in) investing activities  (2,783)      4,123
                                                         --------    --------
CASH FLOWS FROM FINANCING ACTIVITIES

     Proceeds from issuance of common stock                  151          82
     Repayments of capital lease obligations                (135)        (20)
     Repayments of long-term obligations                    (362)    (12,783)
     Tax benefit from exercise of stock options              244          12
     Other                                                  (149)          0
                                                         ---------   --------
    Net cash used in financing activities                   (251)    (12,709)
                                                         ---------   --------  
     Net decrease in cash and temporary
     cash investments                                     (1,225)     (9,294)

  Cash and temporary cash investments, beginning
     of period (reflects Cabot cash as of Dec 31, 1995)    2,882      17,586
                                                         ---------   -------- 
  Cash and temporary cash investments, end of period   $   1,657   $   8,292
                                                         =========   ======== 
SUPPLEMENTAL DISCLOSURES

     Cash paid for interest                            $   2,592   $      66
                                                         ========    ======== 
     Cash paid for income taxes                        $     176   $     274
                                                         ========    ========

                           The accompanying notes are an integral part of
                                    these consolidated statements.







ITEM 2.   Management's Discussion and Analysis of Operations and Financial
          Condition

     RESULTS OF OPERATIONS
     ---------------------


               Three Months Ended March 31, 1996
         Compared to Three Months Ended March 31, 1995

     Sales
     -------

     Total sales of $40.0 million were up 5.4% over first quarter 1995. 
U.S. sales force sales and international sales increased 9% and 7%, 
respectively.  These were partially offset by a 19% decrease in dealer
sales and a 16% decrease in industrial sales.  Price increases accounted
for 1% of the sales increase.

     Gross Profit
     -------------
     First quarter gross profit totaled $22.2 million or 55.5% of sales
compared to $20.5 million or  54.1% for the same period last year.
The improvement was the result of increased manufacturing efficiencies
and sales of higher margin products.

     Operating Expense
     -----------------
     Total operating expenses increased 1% over first quarter 1995 as
compared to a 5.4% sales increase.  Selling and general administrative
expense decreased 1.2% reflecting economies gained from the merger
of Circon and Cabot.

     Research and development expenditures totaled $3.0 million, up
14% over prior year reflecting continued emphasis on new product 
development.  As a percent of sales, R&D expense was 7.4% compared
to 6.9% for prior year.

     Income from Operations
     -----------------------
     Operating income was up 73% to $3.6 million due to increased
sales and gross profits and operating expense trends discussed above.

     Interest and Other Expense
     --------------------------
     Interest expense of $1,128,000 decreased $312,000 from prior year
due to reduced loan balances.  Interest income of $95,000 decreased
$268,000 from prior year due to lower investment balances.

     Income Taxes
     -------------
     The provision for income taxes of 33% compared to 35.5% in 1995
decreased due to the ability of the company to utilize some of the NOL from
 Cabot.

     Net Income
     -----------
     Net income of $1.7 million was up 167% over comparable 1995 due
to increased sales and higher profit margins.

     Subsequent Events
     ------------------
     The company will be closing Cabot Medical's smaller facility in
Langhorne, Pennsylvania, and taking other consolidating actions by the end
of the third quarter 1996.  As a result of this consolidation and related tax
benefits, Circon is targeting after tax benefits of $0.8 million in 1996,
(including a credit of approximately $2.0 million to the provision for income
taxes resulting from the liquidation of Cabot and related realization of
Cabot tax benefits), $1.8 million in 1997 and each subsequent year
compared to not taking these actions.  The targeted one time operating cost,
associated with closing the facility, is $1.8 million in 1996, but will yield
$2.6 million in operating cost savings in 1997 and each subsequent year 
compared to not consolidating.

     This consolidation is targeted to produce a $0.8 million benefit in
the second quarter, (including a credit of approximately $2.0 million to the
provision for income taxes resulting from the liquidation of Cabot and 
related realization of Cabot tax benefits), a $0.2 million cost in the third
quarter and a benefit of $0.2 million in the fourth quarter, for a full year
1996 after tax benefit of $0.8 million.  In the years 1997 and beyond, the
after tax benefit is targeted for $0.45 million per quarter or $1.8 million
per year.

     The major costs associated with closing the facility and relocating
the production activities are targeted to occur in the second quarter and
total $1.8 million for 1996.  By the fourth quarter, operating savings of
$0.3 million are targeted.  In the years 1997 and beyond, this consolidation
is targeted to produce operational savings of $0.65 million per quarter
or $2.6 million per year.


                Liquidity and Capital Resources
               --------------------------------  
     Circon has a $75.0 million secured revolving credit line with a 
syndicate of banks. $50.5 million of this facility was used to repurchase
Cabot notes in January 1996 (see note 2).

     As of March 31, 1996, the company had cash and marketable
securities totaling  $8.9 million.

     The company believes that cash flow from operations, existing
cash and marketable securities and available cash from bank credit 
facilities are adequate to fund the company's existing operation for the
foreseeable future.


                            SIGNATURES





Pursuant to the requirements of the Securities Exchange
Act of 1934, this amended report has been signed below
bt the Chief Accounting Officer.

                

Fred Wallach        Vice President, Controller     June 4, 1996 








© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission